AR045865A1 - El uso de un polifenol para el tratamiento de una lesion cancerosa o pre-cancerosa de la piel - Google Patents
El uso de un polifenol para el tratamiento de una lesion cancerosa o pre-cancerosa de la pielInfo
- Publication number
- AR045865A1 AR045865A1 ARP040103652A ARP040103652A AR045865A1 AR 045865 A1 AR045865 A1 AR 045865A1 AR P040103652 A ARP040103652 A AR P040103652A AR P040103652 A ARP040103652 A AR P040103652A AR 045865 A1 AR045865 A1 AR 045865A1
- Authority
- AR
- Argentina
- Prior art keywords
- polyphenol
- cancerose
- canceral
- treatment
- skin injury
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Método para tratar lesiones cancerosas o pre-cancerosas de la piel mediante la administración de una cantidad farmacéuticamente efectiva de un polifenol (catecol, gallato de catecol, epicatecol, callato de epicatecol, epigallocatecol, callato de epigallocatecol, callocatecol, callato de gallocatecol, entre otros), a un paciente y producción de un medicamento para lo mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51010103P | 2003-10-09 | 2003-10-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR045865A1 true AR045865A1 (es) | 2005-11-16 |
Family
ID=34465119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040103652A AR045865A1 (es) | 2003-10-09 | 2004-10-08 | El uso de un polifenol para el tratamiento de una lesion cancerosa o pre-cancerosa de la piel |
Country Status (13)
Country | Link |
---|---|
US (3) | US7910138B2 (es) |
EP (2) | EP1684780B1 (es) |
AR (1) | AR045865A1 (es) |
AU (1) | AU2004281525B2 (es) |
BR (1) | BRPI0415215B8 (es) |
CA (1) | CA2541405C (es) |
ES (1) | ES2391561T3 (es) |
IL (1) | IL174434A0 (es) |
MX (1) | MXPA06003404A (es) |
NZ (1) | NZ546323A (es) |
RU (1) | RU2366447C2 (es) |
WO (1) | WO2005037300A1 (es) |
ZA (1) | ZA200602544B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2319626T3 (es) * | 2001-11-19 | 2009-05-11 | Medigene Ag | Farmaco para el tratamiento de enfermedades tumorales y de la piel virales. |
US20050079235A1 (en) * | 2003-10-09 | 2005-04-14 | Eggert Stockfleth | Use of a polyphenol for the treatment of actinic keratosis |
ES2552108T3 (es) * | 2005-03-11 | 2015-11-25 | Howard Florey Institute Pty Ltd | Compuestos flavonoides y usos de los mismos |
JP6855240B2 (ja) | 2013-09-27 | 2021-04-07 | メビオン・メディカル・システムズ・インコーポレーテッド | 粒子ビーム走査 |
US10675487B2 (en) | 2013-12-20 | 2020-06-09 | Mevion Medical Systems, Inc. | Energy degrader enabling high-speed energy switching |
US9962560B2 (en) | 2013-12-20 | 2018-05-08 | Mevion Medical Systems, Inc. | Collimator and energy degrader |
WO2015090853A1 (en) * | 2013-12-20 | 2015-06-25 | Unilever N.V. | Sunless tanning |
US9661736B2 (en) | 2014-02-20 | 2017-05-23 | Mevion Medical Systems, Inc. | Scanning system for a particle therapy system |
US10786689B2 (en) | 2015-11-10 | 2020-09-29 | Mevion Medical Systems, Inc. | Adaptive aperture |
WO2018009779A1 (en) | 2016-07-08 | 2018-01-11 | Mevion Medical Systems, Inc. | Treatment planning |
US11103730B2 (en) | 2017-02-23 | 2021-08-31 | Mevion Medical Systems, Inc. | Automated treatment in particle therapy |
WO2019006253A1 (en) | 2017-06-30 | 2019-01-03 | Mevion Medical Systems, Inc. | CONFIGURABLE COLLIMATOR CONTROLLED BY LINEAR MOTORS |
JP2022524103A (ja) | 2019-03-08 | 2022-04-27 | メビオン・メディカル・システムズ・インコーポレーテッド | カラム別の放射線の照射およびそのための治療計画の生成 |
IT201900003843A1 (it) * | 2019-03-15 | 2020-09-15 | Lo Li Pharma Srl | Trattamento di fibromi con vitamina D e un agente come l'epigallocatechina gallato (EGCG) |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4002775A (en) | 1973-07-09 | 1977-01-11 | Kabara Jon J | Fatty acids and derivatives of antimicrobial agents |
JPS55105677A (en) | 1979-02-07 | 1980-08-13 | Norin Suisansyo Chiyagiyou Shikenjo | Production of catechins |
US4306568A (en) * | 1979-12-04 | 1981-12-22 | Torre Douglas P | Method and apparatus for congelation cryometry in cryosurgery |
EP0087161A3 (en) | 1982-02-24 | 1984-04-04 | Key Pharmaceuticals, Inc. | Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament |
JPS59219384A (ja) | 1983-05-30 | 1984-12-10 | Mitsui Norin Kk | 天然抗酸化剤の製造方法 |
JPS6013780A (ja) | 1983-07-05 | 1985-01-24 | Mitsui Norin Kk | 茶カテキン類の製造方法 |
JPS61238728A (ja) | 1985-04-16 | 1986-10-24 | Mitsui Norin Kk | 茶葉抽出物と活性水酸化アルミニウムとの抗潰瘍性複合体 |
US4672810A (en) | 1985-10-15 | 1987-06-16 | Marlowe Christian P | Hydraulic transmission device and method of using it |
SE462894B (sv) | 1985-10-28 | 1990-09-17 | Biogram Ab | Mikrokapslar, foerfarande foer framstaellning daerav samt anvaendning |
US4863970A (en) | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
US5204089A (en) | 1989-08-30 | 1993-04-20 | Mitsui Norin Co., Ltd. | Method of preventing the formation or aggrevation of dental plaque and method for reducing cariogenesis |
JP2727471B2 (ja) | 1989-09-14 | 1998-03-11 | 三井農林株式会社 | インフルエンザウィルス感染予防剤 |
JP2888554B2 (ja) | 1989-09-20 | 1999-05-10 | 三井農林株式会社 | マイコプラズマ感染予防剤 |
US5318986A (en) | 1989-10-19 | 1994-06-07 | Mitsui Norin Co., Ltd. | Method of inhibiting the activity of α-amylase |
US5063787A (en) * | 1989-11-22 | 1991-11-12 | General Electric Company | Venturi arrangement |
US5358713A (en) | 1990-02-23 | 1994-10-25 | Mitsui Norin Co., Ltd. | Method of preventing the transmission of infection caused by methicillin-resistant Staphylococcus aureus |
JP3019996B2 (ja) | 1990-03-01 | 2000-03-15 | 三井農林株式会社 | 白癬治療剤 |
JPH04253918A (ja) | 1991-02-05 | 1992-09-09 | Mitsui Norin Kk | 血糖上昇抑制剤 |
US5303486A (en) * | 1992-05-04 | 1994-04-19 | Dell Gay D | Quilting hoop |
ZA933895B (en) | 1992-06-08 | 1993-12-27 | Pitmy Int Nv | Dermatological composition |
US5306486A (en) | 1993-03-01 | 1994-04-26 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic sunscreen composition containing green tea and a sunscreen |
JP3333584B2 (ja) | 1993-04-19 | 2002-10-15 | 三井農林株式会社 | 歯質の耐酸性強化組成物 |
US5670154A (en) | 1994-01-10 | 1997-09-23 | Mitsui Norin Co., Ltd. | Reducing tyrosinase activity |
FR2718022B1 (fr) | 1994-04-01 | 1996-04-26 | Roussel Uclaf | Compositions cosmétiques ou dermatologiques et leur préparation. |
IL115156A (en) | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
JP2718653B2 (ja) | 1995-01-31 | 1998-02-25 | 日本配合飼料株式会社 | 新規卵および卵質改良方法 |
IT1275905B1 (it) | 1995-03-14 | 1997-10-24 | Indena Spa | Frazioni polifenoliche di te', loro uso e formulazioni che le contengono |
GB2300578B (en) | 1995-05-11 | 1998-01-14 | Matsushita Seiko Kk | Gargling cup,antiviral mask,antiviral filter,antifungal,antibacterial,and antiviral filter air cleaner and air-cleaner-humidifier |
US5888527A (en) | 1995-05-11 | 1999-03-30 | Matsushita Seiko Co., Ltd. | Gargling cup, antiviral mask, antiviral filter, antifungal, antibacterial, and antiviral filter air cleaner and air-cleaner humidifier |
JPH09132532A (ja) | 1995-09-06 | 1997-05-20 | Mitsui Norin Kk | 抗生物質の抗菌力増強方法 |
US6127393A (en) | 1995-12-29 | 2000-10-03 | Novactyl, Inc. | Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method |
US5804567A (en) | 1996-07-18 | 1998-09-08 | Cancer Institute (Hospital), Chinese Academy Of Medical Sciences | Method of increasing the effectiveness of anti-metabolites |
US6337320B1 (en) * | 1996-10-11 | 2002-01-08 | Thione International, Inc. | Reparatives for ultraviolet radiation skin damage |
EP0941087B1 (en) | 1996-11-14 | 2009-09-16 | Lipomedica ehf. | Topical formulations containing as a therapeutic active agent a monoglyceride for treating of mucosa infections |
JP3213557B2 (ja) | 1996-11-18 | 2001-10-02 | 三井農林株式会社 | 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤 |
US5968973A (en) | 1996-11-18 | 1999-10-19 | Cancer Institute (Hospital), Chinese Academy Of Medical Sciences | Method for treating hyperplasia |
US6197808B1 (en) | 1996-11-18 | 2001-03-06 | Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences | Methods for treating hyperplasia |
US20020198161A1 (en) * | 1997-02-20 | 2002-12-26 | Douglas E. Brash | Therapeutic uses of antioxidants |
JP3202938B2 (ja) | 1997-03-18 | 2001-08-27 | 三井農林株式会社 | チューインガム及びその製造法 |
US5910308A (en) | 1997-03-19 | 1999-06-08 | Sante International Inc. | Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis |
US6372234B1 (en) | 1997-05-27 | 2002-04-16 | Sembiosys Genetics Inc. | Products for topical applications comprising oil bodies |
US6696484B2 (en) | 1997-10-31 | 2004-02-24 | University Of Chicago Office Of Technology And Intellectual Property | Method and compositions for regulation of 5-alpha reductase activity |
AU1289899A (en) | 1997-10-31 | 1999-05-24 | Arch Development Corporation | Methods and compositions for regulation of 5-alpha reductase activity |
CN1139382C (zh) | 1998-04-21 | 2004-02-25 | 三井农林株式会社 | 抗衣原体剂 |
US20020006447A1 (en) | 1998-04-21 | 2002-01-17 | Mitsui Norin Co., Ltd. | Anti-chlamydia agent |
DE19827624A1 (de) | 1998-06-20 | 1999-12-23 | Beiersdorf Ag | Verwendung von einem mit einem Gehalt an Catecinen oder einem Gehalt an Extrakt von grünem Tee in kosmetischen Zubereitungen zur Bräunung der Haut |
SE9803929D0 (sv) | 1998-11-18 | 1998-11-18 | Medivir Ab | Antiviral formulation |
KR100319973B1 (ko) | 1998-12-05 | 2002-04-22 | 이인수 | 녹차카테킨을 유효성분으로 하는 자궁경부 상피내종양 예방 또는 치료제 조성물 |
US6210679B1 (en) | 1999-01-07 | 2001-04-03 | Hauser, Inc. | Method for isolation of caffeine-free catechins from green tea |
DE19962369A1 (de) | 1999-12-23 | 2001-06-28 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Catechinen oder einem Gehalt an Extrakt von grünem Tee und einem weiteren Gehalt an Ascorbinsäure |
US6248341B1 (en) * | 2000-01-14 | 2001-06-19 | Color Access, Inc. | Method of treating topical angiogenesis-related disorders |
US20020031535A1 (en) * | 2000-09-11 | 2002-03-14 | Sheffield Felix H. | Topical formulation to treat skin disorders |
US6713506B2 (en) * | 2000-10-11 | 2004-03-30 | University Of South Florida | Tea polyphenol esters and analogs thereof for cancer prevention and treatment |
ES2319626T3 (es) | 2001-11-19 | 2009-05-11 | Medigene Ag | Farmaco para el tratamiento de enfermedades tumorales y de la piel virales. |
US20030143165A1 (en) * | 2002-01-25 | 2003-07-31 | Allan Evans | NSAID-containing topical formulations that demonstrate chemopreventive activity |
US20030166583A1 (en) * | 2002-02-22 | 2003-09-04 | Oliver Yoa-Pu Hu | Dermal cytochrome P450 1A inhibitors and enhancers |
US6723750B2 (en) * | 2002-03-15 | 2004-04-20 | Allergan, Inc. | Photodynamic therapy for pre-melanomas |
BRPI0204130B8 (pt) | 2002-09-18 | 2021-05-25 | Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp | composição gel à base de extrato de pothomorphe umbellata, seus usos e método cosmético não-terapêutico. |
US20040191842A1 (en) | 2002-12-10 | 2004-09-30 | Medical College Of Georgia Research Institute, Inc. | Chemopreventive and therapeutic aspects of polyphenolic compositions and assays |
US6817511B2 (en) * | 2002-12-16 | 2004-11-16 | Dana Corporation | Method for joining axle components |
CA2518082C (en) | 2003-03-13 | 2013-02-12 | 3M Innovative Properties Company | Methods for diagnosing skin lesions |
US20050079235A1 (en) | 2003-10-09 | 2005-04-14 | Eggert Stockfleth | Use of a polyphenol for the treatment of actinic keratosis |
-
2004
- 2004-10-08 BR BRPI0415215A patent/BRPI0415215B8/pt active IP Right Grant
- 2004-10-08 EP EP04790231A patent/EP1684780B1/en active Active
- 2004-10-08 AU AU2004281525A patent/AU2004281525B2/en active Active
- 2004-10-08 CA CA2541405A patent/CA2541405C/en active Active
- 2004-10-08 ES ES04790231T patent/ES2391561T3/es active Active
- 2004-10-08 AR ARP040103652A patent/AR045865A1/es unknown
- 2004-10-08 ZA ZA200602544A patent/ZA200602544B/en unknown
- 2004-10-08 EP EP10012395A patent/EP2292226A3/en not_active Ceased
- 2004-10-08 NZ NZ546323A patent/NZ546323A/xx unknown
- 2004-10-08 RU RU2006115603/15A patent/RU2366447C2/ru active
- 2004-10-08 WO PCT/EP2004/011300 patent/WO2005037300A1/en active Application Filing
- 2004-10-08 US US10/574,422 patent/US7910138B2/en not_active Expired - Fee Related
- 2004-10-08 MX MXPA06003404A patent/MXPA06003404A/es active IP Right Grant
-
2006
- 2006-03-21 IL IL174434A patent/IL174434A0/en active IP Right Grant
-
2011
- 2011-03-18 US US13/051,593 patent/US8455022B2/en active Active
-
2013
- 2013-05-07 US US13/888,949 patent/US9060998B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2541405A1 (en) | 2005-04-28 |
AU2004281525B2 (en) | 2010-01-28 |
RU2006115603A (ru) | 2007-11-27 |
US9060998B2 (en) | 2015-06-23 |
MXPA06003404A (es) | 2006-06-27 |
US20130245113A1 (en) | 2013-09-19 |
AU2004281525A1 (en) | 2005-04-28 |
US20110166219A1 (en) | 2011-07-07 |
RU2366447C2 (ru) | 2009-09-10 |
EP1684780A1 (en) | 2006-08-02 |
CA2541405C (en) | 2014-07-29 |
IL174434A0 (en) | 2006-08-01 |
BRPI0415215A (pt) | 2006-12-05 |
ES2391561T3 (es) | 2012-11-27 |
EP2292226A3 (en) | 2011-08-10 |
EP2292226A2 (en) | 2011-03-09 |
US8455022B2 (en) | 2013-06-04 |
US7910138B2 (en) | 2011-03-22 |
BRPI0415215B8 (pt) | 2021-05-25 |
EP1684780B1 (en) | 2012-07-25 |
WO2005037300A1 (en) | 2005-04-28 |
NZ546323A (en) | 2009-04-30 |
US20070059387A1 (en) | 2007-03-15 |
ZA200602544B (en) | 2007-06-27 |
BRPI0415215B1 (pt) | 2021-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR045865A1 (es) | El uso de un polifenol para el tratamiento de una lesion cancerosa o pre-cancerosa de la piel | |
AR070047A1 (es) | Tratamientos terapeuticos contra el cancer. composicion que comprende un inhibidor de hedgehog. | |
AR072442A1 (es) | Metodo para la terapia del cancer, uso, kit | |
MXPA05011208A (es) | Uso de ivermectina para el tratamiento de desordenes dermatologicos. | |
CU23208A3 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea | |
AR054249A1 (es) | Tratamiento de enfermedades del tejido conectivo de la piel | |
AR062402A1 (es) | Uso de compuestos y derivados de 2,5-dihidroxibenceno para el tratamiento del cancer de piel | |
BR0315337A (pt) | Composto, formulação farmacêutica, e, método para tratar câncer | |
ES2267706T3 (es) | Agentes como la nicotinamida o cardr para el tratamiento de trastornos de la piel. | |
AR060019A1 (es) | Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo | |
WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
MX2008002456A (es) | Uso de ambroxol para el tratamiento de infecciones por rinovirus. | |
CL2012001671A1 (es) | Compuestos derivados de (metilsulfonil)-etil-bencenoisoindolina; composicion farmaceutica que los comprende, uso en el tratamiento del cancer, dolor, trastornos del snc, enfermedades dermatologicas, entre otras. | |
CY1111353T1 (el) | Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης | |
AU2001266289A1 (en) | 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury | |
CL2008002466A1 (es) | Composicion farmaceutica topica anhidra que comprende un vasodilatador y un vehiculo aceptable; uso de la composicion anhidra topica en las areas genitales para obtener bienestar sexual mejorado. | |
FI4061344T3 (fi) | 6-hydroksikannabidioli käytettäväksi lääkkeenä | |
ECSP077843A (es) | Tratamiento o prevención del prurito | |
BR0112280A (pt) | Nova utilização para deferiprona | |
WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
NO20071238L (no) | Fremgangsmater for leging av skader ved human IL-18 administrering | |
WO2016081296A3 (en) | Topical medicament for skin and mucosal injuries associated with epidermolisis bullosa | |
CL2008002465A1 (es) | Composición farmacéutica anhidra tópica, que comprende derivados de niacina y un portador aceptable, su aplicacón permite un bienestar sexual mejorado. | |
CR8584A (es) | Piperazinas derivadas de urea para el tratamiento de la endometrosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |